Babies before business: protecting the integrity of health professionals from institutional conflict of interest

被引：7

作者：

Becker, Genevieve Ellen ^{[1
]}

Ching, Constance ^{[2
]}

Nguyen, Tuan T. ^{[3
]}

Cashin, Jennifer ^{[2
]}

Zambrano, Paul ^{[4
]}

Mathisen, Roger ^{[3
]}

机构：

[1] BEST Serv, Galway, Ireland

[2] Alive & Thrive Southeast Asia, FHI Solut FHI 360, Washington, DE USA

[3] Alive & Thrive Southeast Asia, FHI Solut FHI 360, Hanoi, Vietnam

[4] Alive & Thrive Southeast Asia, FHI Solut FHI 360, Manila, Philippines

来源：

BMJ GLOBAL HEALTH | 2022年 / 7卷 / 08期

基金：

比尔及梅琳达.盖茨基金会;

关键词：

Child health; Health policy; Health systems; Public Health; Maternal health;

D O I：

10.1136/bmjgh-2022-009640

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Manufacturers and distributors of commercial milk formula (CMF), or breast milk substitutes (BMS), a US$ 55 billion industry,1 have a duty to their shareholders to maximise sales. Marketing increases CMF sales - but reduces breastfeeding. The health system and those who work within it have a primary obligation to preserve and improve health outcomes. Fulfilling this obligation requires that breastfeeding is protected, supported and promoted. These two interests - maximising CMF sales and protecting, supporting and promoting breastfeeding - directly conflict with each other. Conflicts of interest (COI) arise within practices such as sponsorship and funding that bind companies and health systems together.2 In these situations, professional judgement concerning a primary interest (unequivocal support for breastfeeding) tends to be unduly influenced by a secondary interest (sponsorship by or partnership with industry).3 This conflict is even more evident when CMF marketing targets the health system itself. ©

引用

页数：4